يعرض 1 - 10 نتائج من 46 نتيجة بحث عن '"Aurélie Perraud"', وقت الاستعلام: 0.91s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    المساهمون: Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées, University of California [San Diego] (UC San Diego), University of California, Hôpital Beaujon, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Institut Curie [Paris], Queen Mary University of London (QMUL), Université de Limoges (UNILIM), Barts Cancer Institute [London, UK], Cancer Research UK, CRUK: A27947 Fondation pour la Recherche Médicale, FRM: FRM ING20150532688, 40493 Ligue Contre le Cancer: RAB17029BBA, RMA04002BPA, RAB20008BBA PLBIO2015‐115, PAIR 2018‐080, IP/SC16060 G16001BB, We thank Dr Frédéric Lagarrigue (IPBS, Toulouse) for his help with beta‐1 integrin assay, and Marcin Domagala and Sophie Gazzola (CRCT, Toulouse) for their advice on macrophage experiments. We thank Laetitia Ligat (CRCT), Sophie Allart (CPTP) and Astrid Canivet‐Laffitte (CPTP) for their help and expertise in microscopy, Manon Farce (CRCT) for her help and flow cytometry expertise, and Loic Van Den Berghe and Christelle Segura for their help in lentivirus production and expertise in vectorology. The authors also acknowledge Dr Francois‐Xavier Frenois from the Imag'IN platform (IUC, Toulouse, France) for his help and expertise on Definiens Tissue Studio® and Dr Pedro Cutillas from the Centre for Haemato‐Oncology (Barts Cancer Institute, Queen Mary University of London, UK). We would like to thank Servier Medical Art ( https://smart.servier.com ) for graphics used in the figures. This work was supported by LNCC (Ligue Nationale Contre le Cancer RAB20007BBA, RAB20008BBA and RAB17029BBA), the Canceropole Grand Sud‐Ouest (RMA04002BPA), the Labex TOUCAN, the Toulouse University IDEX (G16001BB), the PHUC CAPTOR, la Fondation Bristol‐Myers Squibb and the French National Institute of Cancer (INCa, PLBIO2015‐115, PAIR 2018‐080). I.B is a recipient of LNCC fellowship (IP/SC16060). E.D. and J.R. salaries are funded, respectively, by Fondation pour la Recherche Médicale (FRM ING20150532688) and the French National Institute of Cancer (PLBIO2015‐115), R.S. was a recipient of a fellowship from FRM (#40493). C.J. was recipient of a fellowship from the LNCC. O.M.T.P is a recipient of a Cancer Research UK and Credit Suisse fellowship (A27947).

    المصدر: EMBO Molecular Medicine
    EMBO Molecular Medicine, Wiley Open Access, 2020, 12 (11), ⟨10.15252/emmm.202012010⟩
    EMBO Molecular Medicine, Vol 12, Iss 11, Pp n/a-n/a (2020)